Objectives: To quantify the impact of varying the at-risk days definition on the overall report of at-risk days and on the calculated standardized consumption rates (SCRs) for piperacillin/tazobactam, amikacin, daptomycin and vancomycin.
Introduction
Antimicrobial stewardship programmes (ASPs) are responding to the crisis of antibiotic overuse and resistance. An important metric for all ASPs is antimicrobial utilization. 1 By defining inappropriate antibiotic use, identifying consumption trends and analysing patterns within the institution, stewards can define, measure, analyse and improve acceptable antibiotic utilization. 2 ASPs are tasked with creating strategic plans and establishing programmatic goals. 1 Antibiotic consumption trends and benchmarks are powerful tools that ASPs can use to measure their impact. Therefore, the reliability of the data sources used to quantify antibiotic consumption is of great importance to ASPs. Utilization can be broadly classified using antibiotic order or administration data and classified by the dose in g/day (i.e. DDD) 3 or by the number of days of therapy (DOT). 4 These measures are reported across a given facility, summed over a given month and standardized to a report of patients within the facility at risk of receiving antibiotics. While consumption rates are tabulated by acute care hospitals, the definitions used to obtain these measures are variable. 5 Within the USA, the CDC National Healthcare Safety Network (NHSN) provides institutions with the option of participating in the Antimicrobial Use (AU) module. AU utilizes standardized Health Level 7 Clinical Document Architecture. 6 Because AU utilizes stable and consistent data sources and definitions, it is possible to generate benchmarks across multiple centres nationally.
AU definitions offer antimicrobial stewards a means by which to benchmark their utilization. However, AU participation is not mandatory within the USA. We previously compared standardized consumption rates (SCRs) using DOT/1000 patient days (PD) using financial records and DOT/1000 days present (DP; the AU denominator). We found a high correlation (R 2 " 0.99) between methods across multiple agents after correcting for a 2-fold difference in rates. 7 Our observation led us to question whether this divergence between consumption measures was entirely due to the differences in the denominators. A firm understanding of denominator definitions is especially important in establishing standardized consumption benchmarks. 8 We hypothesized that minor alterations in denominator definitions would significantly influence the resulting SCRs, limiting the ability of centres to compare and benchmark their consumption. Here, we quantify the impact of varying the denominator definitions of at-risk days on the calculated SCRs for several commonly utilized broad-spectrum inpatient antibiotics.
Methods

Design and data sources
This was a retrospective, epidemiological, database review. We reviewed tabulations of antibiotic administrations and at-risk denominator days as captured by the electronic medical record (Cerner, Millennium, Kansas City, MO, USA) or the admission-discharge-transfer system (Epic Systems Corporation, Verona, WI, USA) over 12 months in 2016. Antibiotic administration and denominator data were extracted from these sources using the Northwestern Medicine V R Enterprise Data Warehouse (EDW). The EDW is a large database system that aggregates information from .50 different systems across Northwestern Medicine Healthcare. We extracted data from 25 physically and demographically distinct inpatient ward or ICU data sources at Northwestern Memorial Hospital (NMH), an 894 bed academic medical centre. To extend and increase generalizability of our analysis, we extracted data from Northwestern Lake Forest Hospital (NLFH), a 114 bed community hospital. Data were extracted from 12 physically distinct inpatient ward or ICU data sources and aggregated over a 12 month period from January to December 2016. At-risk days were defined and reported as described in the definitions section and aggregated at the facility-wide inpatient level (i.e. FacWideIn, a synthetic unit comprising all NHSN-mapped inpatient locations). Due to transfers between units, the total sum of at-risk days across all location-specific units could be larger than the total sum of at-risk days at the facility-wide level. Only aggregate counts data were collected and no patient identifiers were collected or used across both centres. The study was classified as non-human subjects research by the institutional review boards of Northwestern University and Midwestern University.
Denominator definitions
The NHSN AU definition was used to generate a report of DP. DP was defined as the aggregate number of patients who were admitted for any fraction of a given calendar day within a given month to a mapped patient care location (http://www.cdc.gov/nhsn/PDFs/pscManual/11pscAURcurrent.pdf). In this method, an inpatient present for any part of a calendar day contributed 1 DP to the overall count.
Hospital administrators utilize daily census counts to generate a report of PD in order to make decisions regarding staffing levels and estimate hospital throughput. For example, an inpatient admitted and occupying a bed for an entire calendar day (i.e. 00:00 to 23:59 h) contributes 1 PD to the overall count.
The Northwestern Healthcare Epidemiology and Infection Prevention (HEIP) group utilizes point-prevalence occupancy data to generate a report of persons present (PP) in order to obtain an at-risk denominator within each facility for the acquisition of hospital-onset infections. PP was assessed using NHSN definitions (https://www.cdc.gov/nhsn/pdfs/patientday_sum data_guide.pdf). An inpatient occupying a bed at 04:00 h on a given calendar day contributed a single PP to the overall count.
Hospital financial officers utilize daily occupancy charges to generate a report of billing days (BD) in order to make financial forecasts and to estimate costs and revenues as a function of hospital throughput. A patient admitted and occupying a bed for an entire calendar day (i.e. 00:00 to 23:59 h) and for whom a room and board charge was applied contributed 1 BD to the overall count. If a room and board charge was not applied, then that patient contributed 0 BD to the overall count on that day.
Antimicrobial administrations
The electronic medical record captures all bar-coded medication administration (BCMA) events within each facility. A DOT for an antimicrobial was defined by a BCMA medication administration event for a given agent received by a patient on a given day. A DOT was equivalent to a single day of therapy, in keeping with the NHSN definitions. For example, if a patient received three doses of intravenous piperacillin/tazobactam on a given day while admitted to the medical intensive care unit (MICU), and did not transfer between units, then this patient would contribute a single DOT to a MICU location-specific report and a single DOT to the facility-wide report of intravenous piperacillin/ tazobactam, consumption. The EDW provided intravenous piperacillin/ tazobactam, amikacin, daptomycin and vancomycin administration data. We assessed DOT over a 12 month period at the facility-wide level.
Statistical analysis
At-risk days were reported monthly for calendar year 2016. Concordance between the at-risk days reported according to the four denominator definitions were evaluated using coefficients of determination (R 2 ) for between-method comparisons. Inter-method comparisons for denominators were generated at the facility-wide level. The concordance between the reports of at-risk days defined according to each of the other definitions versus the DP definition was assessed using least-squares regression. Intermethod similarity between the at-risk days reported according to each of the other definitions versus the DP definition was evaluated using the root mean squared error (RMSE).
Piperacillin/tazobactam, amikacin, daptomycin and vancomycin SCRs were calculated as follows: SCR " (count of DOT/count of at-risk days) % 1000. SCRs were tabulated monthly for each agent and for each of the at-risk days definitions. The concordance between facility-wide SCR calculated according to each of the at-risk days definitions versus DP was determined using least-squares regression. Using piperacillin/tazobactam as a representative antimicrobial, deviation between the SCR values calculated using the at-risk days reported according to each of the other definitions versus the DP definition were identified using 95% predictive intervals. 2, 9 All analyses were conducted in Microsoft Excel 2013 (Redmond, WA, USA).
Results
Within the 894 bed academic hospital, the average monthly facility-wide at-risk days were 28424, 22198, 15957 and 14789 by the DP, PP, PD and BD definitions, respectively. Within the 114 bed community hospital, the average monthly facility-wide at-risk days were 5175, 3523 and 2816 by the DP, PP and PD definitions, respectively. The corresponding average monthly piperacillin/tazobactam SCRs were 68.2, 100.4 and 125.4 DOT/1000 days, respectively. For amikacin, the average monthly SCRs were 0, 0.42 and 0.42 DOT/1000 days by the DP, PP and PD definitions, respectively. For daptomycin, the average monthly SCRs were 3, 4.33 and 5.42 DOT/1000 days by the DP, PP and PD definitions, respectively. For vancomycin, the average monthly SCRs were 63.4, 93.17 and 116.33 DOT/1000 days by the DP, PP and PD definitions, respectively. BD values were not obtainable from the community hospital.
When comparing the academic centre with the community hospital, predictable differences existed. The average DP values within the academic centre were .5-fold greater compared with the community hospital. Likewise, differences in SCR between centres were also observed. Within the academic centre, facilitywide SCR values calculated using PP, PD and BD definitions resulted in divergences of 1.3-to 1.9-fold versus DP; the divergences within the community hospital between the SCR values calculated using the PP and PD definitions were 1.5-to 1.8-fold versus DP.
The time-dependent change in the monthly at-risk days reported according to each of the various definitions is visually depicted in Figure 1 . Across the entire evaluation period, the at-risk days reported according to each definition appeared synchronous within both the academic (Figure 1a ) and the community (Figure  1b) centre. Within the academic centre, the at-risk days reported according to each of the various definitions exhibited distinct slopes and intercepts over time by least-squares regression. The slopes of the best-fit time-dependent linear trends were generally similar irrespective of the definition applied, exhibiting similar time trends (DP, 114; PP, 132; PD, 113; BD, 58). The at-risk days reported according to the DP definition yielded the largest intercept (DP, 27680 days), while the intercepts of the at-risk days reported according to the PP, PD and BD definitions differed substantially from the DP definition (Figure 1a) , reflecting innate differences between the definitions used. The slopes and intercepts of the best-fit linear time trends were generally similar within the community hospital, with intercepts varying substantially by method (Figure 1b) .
Concordance between the various denominator days for each definition were evaluated within the academic medical centre (Table 1 ) and the community hospital (Table 2 ). There was relatively good concordance between the at-risk days reported according to each of the other definitions relative to DP at the facility-wide level within the academic medical centre. Within the community hospital, the facility-wide concordance with DP was moderate with PP and good with PD ( Table 2 ). Within the academic medical centre, the highest degree of concordance with DP was observed with PP (R 2 " 0.97), while the lowest concordance was observed between BD and DP (R 2 " 0.87). Within the community hospital, the highest degree of concordance was observed between PD and DP (R 2 " 0.82), while the lowest concordance was observed between PP and DP (R 2 " 0.45). Inter-method similarity to DP was assessed by minimization of RMSE and is summarized at the facility-wide level for the academic medical centre (Table 1 ) and the community hospital ( Table 2 ). The facility-wide at-risk days with the lowest RMSE (i.e. most similar) versus DP were observed with PP within the academic centre. Within the community hospital, facility-wide at-risk days with the lowest RMSE versus DP were observed with PP.
The facility-wide SCR for piperacillin/tazobactam, amikacin, daptomycin and vancomycin was also calculated each month for the academic medical centre and the community hospital. Within the both the academic and the community hospital, the reported antimicrobial SCRs exhibited synchronicity and mirrored the analysis of monthly at-risk days (data not shown). The concordance between SCRs across piperacillin/tazobactam, amikacin, daptomycin and vancomycin calculated using DP and the corresponding SCR calculated using the alternative denominator definitions are shown in Figure 2 . Within the academic medical centre, the facilitywide SCR calculated using BD (census-based BD) yielded the largest intercept with DP definition (#0.0811). For the community hospital, the facility-wide SCR calculated using PD (census-based PD) yielded the largest intercept with the DP definition (#0.0935). The slopes and intercepts of the best-fit lines were similar across agents, methods and centres, as shown in Figure 2(a and b) . The SCR calculated using PP exhibited the highest concordance with the DP definition ( Figure 2a ; R 2 " 0.9998) within the academic medical centre, whereas the SCR calculated using PD exhibited the highest concordance within the community hospital (Figure 2b ; R 2 " 0.9997). Using piperacillin/tazobactam as a representative example, the 95% predictive interval of the SCR calculated using DP at-risk days included 58.3% (n " 7/12) of the SCR values calculated using PP at-risk days. None of the SCR values calculated using PD or BD at-risk days fell within the DP SCR 95% predictive interval. Within the community hospital, on the other hand, 8.3% (n " 1/12) of the SCR values calculated using PP at-risk days fell inside the DP SCR 95% predictive interval, while all SCR values calculated using PD fell outside the DP SCR 95% predictive interval. R 2 values and slopes of the least-squares regression lines connecting the respective at-risk days are reported according to each definition at the facility-wide level. Data were correlated across all 12 study period months with comparisons made between each specified definition versus DP.
Measuring impact of varying denominator definitions
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Discussion
We found variable concordance between at-risk days reported according to several commonly utilized definitions versus those reported according to the NHSN definition. In a previous investigation, we compared antibiotic utilization as measured by DOT/1000 PD with the NHSN metric of DOT/1000 DP for several Avedissian et al.
broad-spectrum antibiotics within our centre. 7 At-risk days were tabulated using the DP definitions in the latter case and using BD in the former. We hypothesized that a principle driver of the discordance between the SCRs calculated using the NHSN definition and the SCRs derived using BD was related to differences in the denominators. In the present study, we found that the at-risk days definition significantly impacted the resulting SCRs across all four agents evaluated. We generated predictive intervals to define deviance between methods over time using piperacillin/tazobactam as a representative antimicrobial. 2 We also assessed inter-method concordance using R 2 and RMSE values to identify which of the definitions produced reported values most similar to the DP definition. This is the first study, to our knowledge, to systematically compare at-risk days and SCR by varying the method used to define at-risk days across multiple hospitals within a system. Our study provides evidence that a major source of variability in antibiotic consumption measurement relates to the source and definition of at-risk days.
The importance of at-risk days in establishing benchmarks is well known. However, clear descriptions of the data sources and definitions used to generate denominators (i.e. at-risk days) have not been consistently reported in consumption studies. [10] [11] [12] The need for high-quality data sources and stable definitions to derive useful denominators has been well characterized in the infection prevention literature. [13] [14] [15] [16] [17] We observed significant variability in consumption rate estimates due to the inherent differences in the at-risk days definitions and data source. Our approach was strengthened by the inclusion of data from both a large academic hospital and a smaller community hospital within our system, increasing external validity. Likewise, the use of RMSE as a metric for intra-method similarity allowed us to identify strong concordances where simple correlations would have failed to detect them. Our findings have implications for determining within-and between-institution consumption benchmarks. For example, consider an acute hospital that utilizes BCMA and electronic medical records data to report numerator days of therapy relying on financial BD as a denominator. After a health system merger and acquisition, it is decided that a common data reporting service will be used for the combined system. The new service captures numerator data in the same manner as before, but the denominator is now defined using PD according to hospital census. Further, one of the facilities acquired in the merger reports numerator and denominator data according to the NHSN definition. Clearly, consumption data will exhibit compatibility issues both within and between institutions in this example. Comparing consumption rates between centres requires deep knowledge of data sources, common data errors, hospital location mapping and the admission-discharge-transfer system data structure. In some cases, deriving a simple 'corrective factor' to compare consumption rates across different methods and systems may not be possible. Thus, it is essential to establish stable denominators using widely accepted definitions to define meaningful benchmarks.
Limitations to this analysis exist. First, this is a retrospective database review at two medical centres and data systems structures are somewhat unique to each centre. However, our findings and methodology can be highly instructive across centres. Second, consumption rates are always subject to residual errors in both numerator and denominator data sources. Nevertheless, our approach highlights the impact that simple alterations in the way at-risk days are defined can have even when the numerator is held constant. Third, we were not able to attribute differences in the denominators to differences in data source as compared with the definitions themselves. Within the community hospital, we were unable to obtain room and board data to define BD. Billing information, antibiotic administrations and unit census data are frequently stored in separate systems and data tables. Thus, differences in each of these systems may also contribute to the variations we observed in the denominator counts. This may at least partially account for the observed heterogeneity between denominator days and SCRs observed across the four antimicrobial agents evaluated. The differences we observed in SCRs has implications for institutions seeking to benchmark using models that adjust using denominator data. 8 We believe that our analysis supports the need for stable and consistent definitions of at-risk days, such as the NHSN definition.
In summary, we have shown that the data source and at-risk days definitions meaningfully impact antibiotic SCR at both large and smaller hospitals. Ultimately, centres seeking to compare consumption rates to benchmark their own utilization will benefit from the use of a standardized denominator. Centres should carefully consider the sources of variability within their consumption data before attempting to compare their past consumption data with other measures.
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